Antimicrobial Wound Dressing Coating for Atraumatic Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antibacterial wound dressings are cytotoxic to human cells, lack elasticity for gaping wounds, and are difficult to remove without causing trauma, while also being ineffective against antibiotic-resistant bacteria.
Innovation Solution
A wound dressing with a plastic mesh overlaid by an absorbent non-woven material, coated with hyaluronic acid and a polypeptide such as polyarginine, polylysine, or polyornithine, providing antimicrobial protection without cytotoxicity and allowing atraumatic removal.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exogenous antimicrobial agents are used in wound dressings, then antimicrobial efficacy is improved, but cytotoxicity to human cells increases
Solution Approach 1:
The patent changes the chemical parameters of the antimicrobial agent by using polycationic peptides with specific molecular weights (1-10 kDa) and specific compositions (rich in arginine, lysine, and ornithine). This parameter change allows the material to maintain antimicrobial efficacy while reducing cytotoxicity, as the specific polycationic structure enables selective interaction with bacterial cells rather than human cells.
Solution Approach 2:
The patent creates a composite material system combining polycationic peptides with hyaluronic acid and collagen. This composite approach enhances antimicrobial efficacy through synergistic effects while the natural biomaterials (hyaluronic acid and collagen) provide biocompatibility and reduce cytotoxicity. The composite structure allows the material to function both as an antimicrobial agent and a wound healing promoter.
2Reliability
If antibacterial materials are used in wound dressings, then antimicrobial protection is improved, but ease of removal deteriorates due to bonding with wound tissue
Solution Approach 1:
The patent changes the physical parameters of the dressing material by controlling the molecular weight of polycationic peptides (1-10 kDa) and their concentration in the coating (0.1-10 mg/mL). These parameter changes create a coating that provides antimicrobial protection through chemical interaction with bacteria, while the physical properties remain compatible with atraumatic removal. The low molecular weight and controlled concentration prevent excessive bonding with wound tissue.
3Reliability
If conventional antibiotics are used to treat antibiotic-resistant bacteria, then treatment effectiveness is maintained, but treatment difficulty increases requiring combination therapies
Solution Approach 1:
The patent extracts the antimicrobial function from conventional antibiotic systems and implements it through a different mechanism - using polycationic peptides that disrupt bacterial cell membranes through electrostatic interactions. This extraction of the core antimicrobial function from the complex antibiotic system eliminates the need for combination therapies and resistance management, providing a simpler single-agent treatment approach that remains effective against resistant strains.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dressing effectively inhibits pathogenic bacteria, including antibiotic-resistant strains, is non-cytotoxic, maintains wound edges, and can be easily removed without causing pain or trauma, promoting wound healing and stability during storage.
Implementation Method 1
a polypeptide selected from polyarginine, polylysine and polyornithine or a mixture of at least two of the aforementioned polypeptides
Implementation Method 2
Another unresolved problem is that known antibacterial wound dressings lack sufficient atraumatic properties, meaning that their wound contact surface bonds with the wound during the healing process
Implementation Method 3
an absorbent non-woven material
Data Source
Figure 1
Figure 2a
Figure 2b
AI summary
The present invention relates to a wound dressing comprising at least one plastic mesh and an absorbent nonwoven material, wherein at least the mesh has an antimicrobial coating. The coating comprises hyaluronic acid and a polypeptide selected from polyarginine, polylysine, and polyornithine, or a mixture of at least two of the aforementioned polypeptides. Furthermore, methods for applying the coating and wound dressings comprising the antimicrobial nonwoven material are described. The coating is characterized by its good biocompatibility and cell compatibility combined with a strong antiseptic effect.